Format

Send to:

Choose Destination

Choroideremia(CHM)

MedGen UID:
944
Concept ID:
C0008525
Disease or Syndrome
Synonyms: CHM; Progressive tapetochoroidal dystrophy
SNOMED CT: Choroideremia (75241009); Tapetochoroidal dystrophy (75241009)
Modes of inheritance:
X-linked inheritance
MedGen UID:
66838
Concept ID:
C0241764
Genetic Function
Sources: HPO, OMIM
A mode of inheritance that is observed for traits related to a gene encoded on the X chromosome.
X-linked dominant inheritance
MedGen UID:
376232
Concept ID:
C1847879
Finding
Sources: HPO, OMIM
A mode of inheritance that is observed for dominant traits related to a gene encoded on the X chromosome. In the context of medical genetics, X-linked dominant disorders tend to manifest very severely in affected males. The severity of manifestation in females may depend on the degree of skewed X inactivation.
 
Gene (location): CHM (Xq21.2)
 
HPO: HP:0001139
Monarch Initiative: MONDO:0010557
OMIM®: 303100
Orphanet: ORPHA180

Disease characteristics

Excerpted from the GeneReview: Choroideremia
Choroideremia (CHM) is characterized by progressive chorioretinal degeneration in affected males and milder signs in heterozygous (carrier) females. Typically, symptoms in affected males evolve from night blindness to peripheral visual field loss, with central vision preserved until late in life. Although carrier females are generally asymptomatic, signs of chorioretinal degeneration can be reliably observed with fundus autofluorescence imaging, and – after age 25 years – with careful fundus examination. [from GeneReviews]
Authors:
Ian M MacDonald  |  Stacey Hume  |  Yi Zhai, et. al.   view full author information

Additional descriptions

From OMIM
Choroideremia is an X-linked disease that leads to the degeneration of the choriocapillaris, the retinal pigment epithelium, and the photoreceptor of the eye (Cremers et al., 1990). The characteristic lesion of choroideremia is chorioretinal scalloped atrophy in the midperipheral fundus, with preservation of the macula (Li et al., 2014). See also choroideremia, deafness, and mental retardation (303110), a contiguous gene deletion syndrome involving the CHM and POU3F4 (300039) genes on Xq21. X-linked deafness-2 with stapes fixation (DFNX2; 304400) is also caused by mutation in the CHM gene.  http://www.omim.org/entry/303100
From MedlinePlus Genetics
Choroideremia is a condition characterized by progressive vision loss that mainly affects males. The first symptom of this condition is usually an impairment of night vision (night blindness), which can occur in early childhood. A progressive narrowing of the field of vision (tunnel vision) follows, as well as a decrease in the ability to see details (visual acuity). These vision problems are due to an ongoing loss of cells (atrophy) in the specialized light-sensitive tissue that lines the back of the eye (retina) and a nearby network of blood vessels (the choroid). The vision impairment in choroideremia worsens over time, but the progression varies among affected individuals. However, all individuals with this condition will develop blindness, most commonly in late adulthood.  https://medlineplus.gov/genetics/condition/choroideremia

Clinical features

From HPO
Choroideremia
MedGen UID:
944
Concept ID:
C0008525
Disease or Syndrome
Choroideremia (CHM) is characterized by progressive chorioretinal degeneration in affected males and milder signs in heterozygous (carrier) females. Typically, symptoms in affected males evolve from night blindness to peripheral visual field loss, with central vision preserved until late in life. Although carrier females are generally asymptomatic, signs of chorioretinal degeneration can be reliably observed with fundus autofluorescence imaging, and – after age 25 years – with careful fundus examination.
Nyctalopia
MedGen UID:
10349
Concept ID:
C0028077
Disease or Syndrome
Inability to see well at night or in poor light.
Constriction of peripheral visual field
MedGen UID:
68613
Concept ID:
C0235095
Finding
An absolute or relative decrease in retinal sensitivity extending from edge (periphery) of the visual field in a concentric pattern. The visual field is the area that is perceived simultaneously by a fixating eye.
Chorioretinal degeneration
MedGen UID:
99273
Concept ID:
C0521683
Pathologic Function
Progressive visual loss
MedGen UID:
326867
Concept ID:
C1839364
Finding
A reduction of previously attained ability to see.
Chorioretinal atrophy
MedGen UID:
884881
Concept ID:
C4048273
Disease or Syndrome
Atrophy of the choroid and retinal layers of the fundus.

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
Follow this link to review classifications for Choroideremia in Orphanet.

Conditions with this feature

Choroideremia
MedGen UID:
944
Concept ID:
C0008525
Disease or Syndrome
Choroideremia (CHM) is characterized by progressive chorioretinal degeneration in affected males and milder signs in heterozygous (carrier) females. Typically, symptoms in affected males evolve from night blindness to peripheral visual field loss, with central vision preserved until late in life. Although carrier females are generally asymptomatic, signs of chorioretinal degeneration can be reliably observed with fundus autofluorescence imaging, and – after age 25 years – with careful fundus examination.
Van den Bosch syndrome
MedGen UID:
162920
Concept ID:
C0796192
Disease or Syndrome
Syndrome that is characterised by intellectual deficit, choroideraemia, acrokeratosis verruciformis, anhidrosis, and skeletal deformities. It has been observed in a single kindred. The syndrome is transmitted as an X-linked recessive trait and may be caused by a small X-chromosome deletion.
Cataract 6, multiple types
MedGen UID:
396229
Concept ID:
C1861825
Disease or Syndrome
Mutations in the EPHA2 gene have been found to cause multiple types of cataract, which have been described as posterior polar, congenital total, complete, and age-related cortical. The preferred title/symbol of this entry was formerly 'Cataract, posterior polar, 1; CTPP1,' and 'Cataract, Age-Related Cortical, 2; ARCC2' was formerly a distinct entry.
Choroideremia-deafness-obesity syndrome
MedGen UID:
763933
Concept ID:
C3551019
Disease or Syndrome
Choroideremia-deafness-obesity syndrome is an X-linked retinal dystrophy characterized by choroideremia, causing in affected males progressive nyctalopia and eventual central blindness. Obesity, moderate intellectual disability and congenital mixed (sensorineural and conductive) deafness are also observed. Female carriers show typical retinal changes indicative of the choroideremia carrier state.

Recent clinical studies

Etiology

Gao FJ, Tian GH, Hu FY, Wang DD, Li JK, Chang Q, Chen F, Xu GZ, Liu W, Wu JH
BMC Ophthalmol 2020 Jun 1;20(1):212. doi: 10.1186/s12886-020-01478-x. PMID: 32487042Free PMC Article
Dan H, Li T, Lei X, Huang X, Xing Y, Shen Y
Biosci Rep 2020 May 29;40(5) doi: 10.1042/BSR20200067. PMID: 32364220Free PMC Article
Fry LE, Patrício MI, Williams J, Aylward JW, Hewitt H, Clouston P, Xue K, Barnard AR, MacLaren RE
JAMA Ophthalmol 2020 Feb 1;138(2):128-135. doi: 10.1001/jamaophthalmol.2019.5071. PMID: 31855248Free PMC Article
Fu DJ, Xue K, Jolly JK, MacLaren RE
Acta Ophthalmol 2019 Jun;97(4):e589-e600. Epub 2018 Dec 21 doi: 10.1111/aos.13973. PMID: 30575280
Hariri AH, Ip MS, Girach A, Lam BL, Fischer MD, Sankila EM, Pennesi ME, Holz FG, Maclaren RE, Birch DG, Hoyng CB, MacDonald IM, Black GC, Tsang SH, Bressler NM, Stepien KE, Larsen M, Gorin MB, Meunier I, Webster AR, Sadda S; For Natural History of the Progression of Choroideremia (NIGHT) Study Group.
Br J Ophthalmol 2019 Jul;103(7):933-937. Epub 2018 Oct 8 doi: 10.1136/bjophthalmol-2018-312620. PMID: 30297337Free PMC Article

Diagnosis

Wood LJ, Jolly JK, Andrews CD, Wilson IR, Hickey D, Cehajic-Kapetanovic J, Maclaren RE
Clin Exp Optom 2021 Jan;104(1):90-94. doi: 10.1111/cxo.13087. PMID: 32372497
Ortiz-Ramirez GY, Villanueva-Mendoza C, Zenteno Ruiz JC, Reyes M, Cortés-González V
Ophthalmic Genet 2020 Dec;41(6):625-628. Epub 2020 Aug 24 doi: 10.1080/13816810.2020.1810283. PMID: 32835561
Gao FJ, Tian GH, Hu FY, Wang DD, Li JK, Chang Q, Chen F, Xu GZ, Liu W, Wu JH
BMC Ophthalmol 2020 Jun 1;20(1):212. doi: 10.1186/s12886-020-01478-x. PMID: 32487042Free PMC Article
Dan H, Li T, Lei X, Huang X, Xing Y, Shen Y
Biosci Rep 2020 May 29;40(5) doi: 10.1042/BSR20200067. PMID: 32364220Free PMC Article
Hariri AH, Ip MS, Girach A, Lam BL, Fischer MD, Sankila EM, Pennesi ME, Holz FG, Maclaren RE, Birch DG, Hoyng CB, MacDonald IM, Black GC, Tsang SH, Bressler NM, Stepien KE, Larsen M, Gorin MB, Meunier I, Webster AR, Sadda S; For Natural History of the Progression of Choroideremia (NIGHT) Study Group.
Br J Ophthalmol 2019 Jul;103(7):933-937. Epub 2018 Oct 8 doi: 10.1136/bjophthalmol-2018-312620. PMID: 30297337Free PMC Article

Therapy

Wood LJ, Jolly JK, Andrews CD, Wilson IR, Hickey D, Cehajic-Kapetanovic J, Maclaren RE
Clin Exp Optom 2021 Jan;104(1):90-94. doi: 10.1111/cxo.13087. PMID: 32372497
Jones KD, Radziwon A, Birch DG, MacDonald IM
Ophthalmic Genet 2020 Aug;41(4):341-344. Epub 2020 May 22 doi: 10.1080/13816810.2020.1768557. PMID: 32441177Free PMC Article
Lam BL, Davis JL, Gregori NZ, MacLaren RE, Girach A, Verriotto JD, Rodriguez B, Rosa PR, Zhang X, Feuer WJ
Am J Ophthalmol 2019 Jan;197:65-73. Epub 2018 Sep 19 doi: 10.1016/j.ajo.2018.09.012. PMID: 30240725
Patrício MI, Barnard AR, Xue K, MacLaren RE
Expert Opin Biol Ther 2018 Jul;18(7):807-820. Epub 2018 Jun 22 doi: 10.1080/14712598.2018.1484448. PMID: 29932012
Ouyang P, Li Y, Zhang F, Zhu C, Zou B, Le J, Zhang L
Mol Med Rep 2018 Jun;17(6):7918-7924. Epub 2018 Apr 5 doi: 10.3892/mmr.2018.8851. PMID: 29620233

Prognosis

Fry LE, Patrício MI, Jolly JK, Xue K, MacLaren RE
Transl Vis Sci Technol 2021 Jul 1;10(8):12. doi: 10.1167/tvst.10.8.12. PMID: 34254989Free PMC Article
Stevanovic M, Cehajic Kapetanovic J, Jolly JK, MacLaren RE
Acta Ophthalmol 2020 May;98(3):e322-e327. Epub 2019 Nov 17 doi: 10.1111/aos.14281. PMID: 31736270
Mucciolo DP, Murro V, Giorgio D, Sodi A, Passerini I, Virgili G, Rizzo S
Ophthalmic Genet 2019 Oct;40(5):421-427. Epub 2019 Sep 21 doi: 10.1080/13816810.2019.1666881. PMID: 31544579
Fu DJ, Xue K, Jolly JK, MacLaren RE
Acta Ophthalmol 2019 Jun;97(4):e589-e600. Epub 2018 Dec 21 doi: 10.1111/aos.13973. PMID: 30575280
Ba-Ali S, Christensen SK, Sander B, Rosenberg T, Larsen M, Lund-Andersen H
Acta Ophthalmol 2017 Dec;95(8):809-814. Epub 2017 Mar 8 doi: 10.1111/aos.13394. PMID: 28271634

Clinical prediction guides

Fry LE, Patrício MI, Jolly JK, Xue K, MacLaren RE
Transl Vis Sci Technol 2021 Jul 1;10(8):12. doi: 10.1167/tvst.10.8.12. PMID: 34254989Free PMC Article
Mucciolo DP, Murro V, Giorgio D, Sodi A, Passerini I, Virgili G, Giansanti F
Eur J Ophthalmol 2021 Nov;31(6):NP81-NP84. Epub 2020 Jul 30 doi: 10.1177/1120672120946576. PMID: 32729722
Wood LJ, Jolly JK, Andrews CD, Wilson IR, Hickey D, Cehajic-Kapetanovic J, Maclaren RE
Clin Exp Optom 2021 Jan;104(1):90-94. doi: 10.1111/cxo.13087. PMID: 32372497
Fry LE, Patrício MI, Williams J, Aylward JW, Hewitt H, Clouston P, Xue K, Barnard AR, MacLaren RE
JAMA Ophthalmol 2020 Feb 1;138(2):128-135. doi: 10.1001/jamaophthalmol.2019.5071. PMID: 31855248Free PMC Article
Stevanovic M, Cehajic Kapetanovic J, Jolly JK, MacLaren RE
Acta Ophthalmol 2020 May;98(3):e322-e327. Epub 2019 Nov 17 doi: 10.1111/aos.14281. PMID: 31736270

Recent systematic reviews

Shen LL, Ahluwalia A, Sun M, Young BK, Grossetta Nardini HK, Del Priore LV
Br J Ophthalmol 2021 Feb;105(2):271-278. Epub 2020 May 29 doi: 10.1136/bjophthalmol-2020-316028. PMID: 32471821Free PMC Article
Shen LL, Ahluwalia A, Sun M, Young BK, Grossetta Nardini HK, Del Priore LV
Ophthalmol Retina 2020 Aug;4(8):840-852. Epub 2020 Mar 14 doi: 10.1016/j.oret.2020.03.003. PMID: 32362554Free PMC Article

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center